发明名称 Compounds for enzyme inhibition
摘要 One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
申请公布号 US8080576(B2) 申请公布日期 2011.12.20
申请号 US20100708932 申请日期 2010.02.19
申请人 SHENK KEVIN D.;PARLATI FRANCESCO;ZHOU HAN-JIE;SYLVAIN CATHERINE;SMYTH MARK S.;BENNETT MARK K.;LAIDIG GUY J.;ONYX THERAPEUTICS, INC. 发明人 SHENK KEVIN D.;PARLATI FRANCESCO;ZHOU HAN-JIE;SYLVAIN CATHERINE;SMYTH MARK S.;BENNETT MARK K.;LAIDIG GUY J.
分类号 A61K31/404;A61K31/336;A61K31/381;C07D209/04;C07D303/02;C07D333/52 主分类号 A61K31/404
代理机构 代理人
主权项
地址